BioCentury | Apr 16, 2021
April 15 Quick Takes: Co-founded by Springer and Kruse, GPCR play Tectonic raises $80M; plus AltruBio, Rapha, Benchling, BioAge, Amgen
Tectonic Therapeutic debuted with an $80 million series A round co-led by Vida Ventures, T.A. Springer, and Polaris Partners to discover and develop of GPCR-targeted therapies. Tectonic was co-founded in 2019 by Andrew Kruse and Timothy...